CMS has advised SYNLAB International GmbH, a leading provider of medical diagnostics in Europe, on the sale of significant parts of its activities in Eastern Europe, specifically the SYNLAB entities in Romania, Croatia, Cyprus, North Macedonia, Slovenia and Turkey, to Medicover Group. This divestment transaction aligns with SYNLAB’s overarching strategy to densify its network by focusing on countries that offer strategic opportunities for SYNLAB Group’s further development. The buyer, Medicover